European Medicines Agency, Amsterdam, the Netherlands
Start date:
3 December 2024
End date:
5 December 2024
Event
Human
Rare diseases
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
2 December 2024
End date:
6 December 2024
Event
Human
Clinical trials
European Medicines Agency, Amsterdam, the Netherlands
Start date:
2 December 2024
End date:
2 December 2024
Event
Human
Research and development
European Medicines Agency, Amsterdam, the Netherlands
Start date:
29 November 2024
End date:
29 November 2024
Event
Corporate
Online
European Medicines Agency, Amsterdam, the Netherlands
Live broadcast
Start date:
28 November 2024, 09:30 (CET)
End date:
28 November 2024, 17:30 (CET)
Event
Human
Medicines
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
Online
Start date:
26 November 2024
End date:
28 November 2024
Event
Human
Clinical trials
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024, 10:00 (CET)
End date:
25 November 2024, 11:30 (CET)
Event
Human
Medicines
Online
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024, 09:00 (CET)
End date:
28 November 2024, 13:30 (CET)
Event
Human
Clinical trials
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024
End date:
25 November 2024
Event
Corporate
European Medicines Agency, Amsterdam, the Netherlands
Start date:
25 November 2024
End date:
28 November 2024
Event
Human
Pharmacovigilance